IFNA1 and systemic lupus erythematosus: Although these findings have resulted in the development of various targeted therapeutic approaches such as depletion of B cells or blockade of IFN signaling, we lack a full understanding of the molecular base of this disease and of the series of events that trigger the observed break in self-tolerance or onset of SLE (17).